Signaling Pathways - Bladder Carcinoma - Immunological Diseases - Lung Carcinoma
清除全部
- B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂
- B2173 CP-673451Target: PDGFRSummary: PDGFRα/β抑制剂
- A1196 SGX-5231 CitationTarget: METSummary: 高度选择性的、ATP竞争性的Met抑制剂
- A1821 Ki8751Target: VEGFRSummary: VEGFR-2有效的、选择性抑制剂
- A3712 PF-04217903 methanesulfonateTarget: c-METSummary: c-Met抑制剂
- A3573 LY2801653Target: METSummary: MET抑制剂
- A4365 Lovastatin中文名: 洛伐他汀Target: HMG-CoA ReductasesSummary: HMG-CoA还原酶抑制剂
- A1915 Zebularine1 Citation中文名: 泽布拉林Target: DNA Methyltransferases|Cytidine deaminasesSummary: DNA甲基化抑制剂
- A4138 Tofacitinib (CP-690550,Tasocitinib)1 Citation中文名: 托法替尼,托法替布Target: JAKSummary: Janus激酶抑制剂